This inventor holds 1 USPTO granted patent. Top assignee: Virginia Commonwealth University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Nirmita J Patel: Innovator in Cancer Therapeutics
Introduction
Nirmita J Patel is a prominent inventor based in Glen Allen, VA (US). He has made significant contributions to the field of cancer therapeutics through his innovative research and patents. His work focuses on the development of novel compounds that target cancer stem cells, which are crucial in the progression and recurrence of cancer.
Latest Patents
Nirmita J Patel holds a patent titled "Sulfated and unsulfated flavonoid oligomers as cancer therapeutics." This patent details the use of sulfated and unsulfated flavonoid oligomers as inhibitors of cancer stem cells (CSCs). In particular, his research demonstrates that sulfated flavonoid dimers can selectively inhibit the growth and self-renewal of CSCs both in vitro and in vivo. This groundbreaking work has the potential to lead to more effective cancer treatments.
Career Highlights
Nirmita J Patel is affiliated with Virginia Commonwealth University, where he conducts his research. His academic and professional journey has been marked by a commitment to advancing cancer treatment methodologies. His innovative approach to targeting cancer stem cells has garnered attention in the scientific community.
Collaborations
Throughout his career, Nirmita has collaborated with esteemed colleagues, including Umesh R Desai and Rajesh Karuturi. These collaborations have enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Nirmita J Patel is a dedicated inventor whose work in cancer therapeutics is paving the way for new treatment options. His patent on flavonoid oligomers highlights the importance of innovative research in combating cancer. His contributions to the field are invaluable and continue to inspire future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
